Conclusions:
The implantation of a FLS, despite supposing around 16% of the percentage of patients treated with bisphosphonates and equivalents in the health area Gran Canaria North derivates from the FLS has not led to an increase in pharmaceutical expenditure for osteoporosis. We believe that one of the reasons for the non-increase in spending is the rational use of drugs for osteoporosis. Background: Patients affected by Rheumatoid Arthritis (RA) show an increased risk of low bone mass, as a result of multi-systemic disorders including toxic drug, low vitamin D levels and physical inactivity. Trabecular Bone Score (TBS), is an index extracted from the dual-energy X-ray absorptiometry (DXA) images, that provides an indirect measurement (Score) of bone axial microarchitecture and allows to get information about bone quality (1,2). Objectives: The aim of this investigation was to evaluate bone quality in RA patients (high risk population) receiving vitamin D supplementation from at least 3 month, using the TBS. Methods: 108 female patients (mean age 61±8 years) affected by RA and 60 age-matched controls (CNT) (mean age 64±11 years) were enrolled. Bone Mineral Density (BMD, g/cm 2 ) of the lumbar spine (L1-L4) was analyzed using a DXA scan (GE,Lunar Prodigy). Lumbar spine TBS (TBS iNsight Medimaps) was derived for each spine DXA examination. All patients were evaluated for serum 25 hydroxyvitamin D (25(OH)D) concentrations. Results: 78 RA patients (80%) presented a bone loss that was significantly lower when compared with control group (p<0.001). Likewise, lumbar spine TBS score was found significantly lower in RA patients compared with CNT (p<0.001). Finally, RA patients showed lower 25(OH)D concentrations (18.4±1.3 ng/ml) than CNT (26.2±0.9 ng/ml; p<0.04).
Conclusions: This study shows in RA patients a reduction of TBS values that seem placed side by side with reduced BMD values and 25(OH)D serum concentrations. Therefore, TBS could become a new and safe diagnostic tool for the quantification of the bone quality and related osteoporosis, in chronic systemic inflammatory rheumatic diseases, such as RA. Background: The association between two chronic inflammatory diseases such as rheumatoid arthritis (RA) and periodontitis (PD) may be explained by causal and noncausal pathways. A possible mechanism in the increased PD observed in patients with RA is systemic bone loss due to the inflammatory process itself among others factors. Several studies have reported associations between OP and PD, not confirmed in other studies. Objectives: 1.To determine whether OP is associated with PD and with PD severity. Methods: Observational cross-sectional, case-control study of RA patients ≥18 y.o. meeting ACR/EULAR 2010 criteria for RA in a Rheumatology Dept. and a control group with a non-inflammatory joint disease, with at least 4 teeth, without dental prophylaxis or antibiotic intake 6 months before. Socio-demographic and anthropometric variables with smoking status,Graffar scale, stress level, annual dental prophylaxis, and co-morbidities such as diabetes mellitus (DM), dyslipidemia (DS), ischemic cardiovascular disease (ICD) and history of lowimpact fractures. Dual-energy x-ray absorptiometry (DXA) (g/cm 2 ) was performed with a DXA LUNAR (GE HealthCare) in lumbar spine and femoral neck. Periodontal Variables included plaque index, bleeding on probing, probing pocket depth, recession, clinical attachment level (CAL). Full mouth CAL and periapical x-rays were taken. CAL was classified according to the European Workshop in 2005 (Tonetti), into level 0 (absence), TL1 (mild), TL2 (severe). Statistical Analysis: t-student test, Kruskal Wallis, Chi-square with Stata 13.1. Results: We studied 344 patients: 187 RA (147 F/40 M) and 157control (101F/56M). Both groups were comparable in age 54.9 (17.9) y.o., body mass index 27.8 (4.6), stress level, DM and ICD. Differences in gender (>no. of males in controls), socioeconomic status (lower level in RA), >no. of current and former smokers RA (19.2%vs 8.9%/24.6%vs 11.5%),OP (23.4% RA vs 7.8%), DS (hipertrygliceridemia 11.2% RA vs 4.4%). PD was found in 97.3% of RA patients vs 66.2% of controls. DEXA was performed in 303 patients: 163 RA/140 controls that showed OP in 38 (23.3%) and 13 (9.3%) of RA and control groups as well as osteopenia in 47 (32.4%) and 16 (11.3%) respectively (p<0.001); 81% of these patients presented PD. There was association between PD and OP/osteopenia, so patients with PD had greater abnormal BMD 88% vs 76.3% with normal BMD; patients without PD showed greater normal BMD with statistically significant difference (23.7% vs 11.1%) (p=0.008). Conclusions: 1. PD was observed in 81% of the patients evaluated with BMD; of these, 89% had OP/ osteopenia, and among the patients without PD a significant normal BMD predominated. 2. PD was found in 97% of RA patients versus 66% of controls; similarly OP was present in 23.3% of RA patients versus 9.3% of controls, with the diference being significant. 3. There was no association between BMD and PD severity. Background: Presence of vertebral body deformities is considered a relevant issue in order to chose a particular treatment in patients with osteoporosis. However, only remarcable deformities are properly identified and registred while those, less striking can just be unnoticed in radiological studies not related to osteporosis studies. One of the most usual radiographic study of the axial skeleton is the lumbar and dorsal acute pain. This group of patients is, indeed, suitable stablish proportions of any grade of vertebral body deformities according to the Genant scale. Objectives: The goal of present study is to determine prevalence of vertebral body deformities in postmenopausial patients radiologically assessed due to lumbar or dorsal non traumatic related pain. Methods: We performed a simple randomization of the registries of female patients with 65 years old or more who consulted due to dorsal or lumbar
